Gates Foundation Pledges $5.7M Toward Ebola Treatment Trials
News outlets report on the Bill & Melinda Gates Foundation’s pledge of $5.7 million to test experimental Ebola treatments in West Africa.
BBC News: Ebola outbreak: $5.7m pledged for blood plasma trials
“The Bill & Melinda Gates Foundation has pledged $5.7m towards a program to increase production of experimental Ebola treatments in Guinea and other affected countries…” (11/18).
Bloomberg News: Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
“The Bill & Melinda Gates Foundation committed $5.7 million to help produce and test potential blood-based therapies and antiviral treatments for Ebola. The funds will support efforts in West Africa to evaluate plasma and other blood products from survivors of Ebola virus disease as a means of treating the infection in others, the Seattle-based foundation said in an e-mailed Nov. 18 statement. Various drug candidates will also be tested, including Chimerix Inc. (CMRX)’s antiviral brincidofovir…” (Gale, 11/18).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.